Litcius/Paper detail

RETRACTED ARTICLE: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug

Amgad M. Rabie

2021Chemical Papers22 citationsDOIOpen Access PDF

Topics & Concepts

FavipiravirVirologyDrug repositioningCoronavirusPharmacologyDrugChemistryDrug discoveryRNA-dependent RNA polymeraseAntiviral drugRNA polymeraseCoronavirus disease 2019 (COVID-19)BiologyEnzymeRNAMedicineBiochemistryPolymeraseGeneDiseaseInfectious disease (medical specialty)PathologySARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research Studiesinterferon and immune responses
RETRACTED ARTICLE: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug | Litcius